Cardiotoxicity testing is a key activity in the pharmaceutical industry in order to detect detrimental effects of new drugs. A reliable human in vitro model would both be beneficial in selection of lead compounds and be important for reducing animal experimentation. However, the human heart is a complex organ composed of many distinct types of cardiomyocytes, but cardiomyocyte clusters (CMCs) derived from human embryonic stem cells could be an option for a cellular model. Data on functional properties of CMCs demonstrate similarities to their in vivo analogues in human. However, development of an in vitro model requires a more thorough comparison of CMCs to human heart tissue. Therefore, we directly compared individually isolated CMCs to human fetal, neonatal, adult atrial and ventricular heart tissues. Real-time qPCR analysis of mRNA levels and protein staining of ion channels and cardiac markers showed in general a similar expression pattern in CMCs and human heart. Moreover, a significant decrease in beat frequency was noted after addition of Zatebradine, a blocker to I f involved in regulation of spontaneous contraction in CMCs. The results underscore the similarities of CMCs to human cardiac tissue, and further support establishment of novel cardiotoxicity assays based on the CMCs in drug discovery.
Introduction
In the pharmaceutical industry, cardiotoxicity testing is a key activity in order to detect potential detrimental effects of new drug molecules. A reliable human in vitro model that could predict cardiotoxicity with high precision as early as possible in the drug discovery process would not only be beneficial in the selection process of lead compounds but also be important for reducing animal experimentation. However, the human heart is an organ which is composed of many distinct functional types of cardiomyocytes as well as other cell types. This makes the development of an in vitro model recapitulating the in vivo complexity extremely challenging.
One option for such a model could be to take advantage of the properties of human embryonic stem cells (hESCs). These cells are pluripotent and possess the capacity of unlimited cell divisions (Thomson et al., 1998) . On the basis of these properties, they hold a great promise for future regenerative medicine applications, as well as for several fields of in vitro studies, such as in drug development . Human ESCs have the ability to differentiate in vitro into a wide range of specialized cells, including cardiomyocytes (Kehat et al., 2001; Mummery et al., 2002) . The cardiomyocytes are typically observed as spontaneously contracting clusters of cells among other non-cardiac cells in differentiated hESC cultures. Human ESC-derived cardiomyocyte clusters (CMCs) have previously been characterized based on their molecular, pharmacological and electrophysiological properties (Norstrom et al., 2006; Sartiani et al., 2007) . Studies have shown that ultrastructural properties, ion channel expression and action potential morphologies appear to systematically develop during the maturation of CMCs, mimicking the course of heart development (Snir et al., 2003; Sartiani et al., 2007) . On the basis of action potential analysis, functional heterogeneity between individual human CMCs has been demonstrated and atrial-, ventricular-and nodal-like phenotypes have been observed (He et al., 2003; Jonsson et al., 2010) .
Fuelling further research in this area is the accumulating data on the functional properties of cardiomyocytes derived from hESCs which demonstrate a similarity between the hESC-derived cells and their in vivo analogues in humans (Steel et al., 2009 ). However, only few studies so far have directly compared the CMCs with human cardiac biopsies from various sources. Thus far, these reports have shown the cardiac gene expression of relatively early CMCs to be similar to that of fetal heart (Beqqali et al., 2006; Cao et al., 2008) . For the development of a reliable in vitro model for cardiotoxicity, a more thorough characterization of CMCs with comparison also to the human adult heart is needed.
To explore whether CMCs are similar to human heart tissue, and thus would constitute a representative cardiac tissue model, we compared a large collection of individually isolated CMCs with human fetal, neonatal and adult heart biopsies. Moreover, both atrial and ventricular samples of adult heart were included in this study. Owing to the heterogeneous nature of CMCs, most studies so far have used pooled samples which therefore constitute mixtures of CMCs of different phenotypes. Here, we have instead, for the first time, analyzed individual CMCs on gene, protein and functional level and grouped the CMCs based on a threshold beat frequency levels of 50 beats per minute (BPM), which can be used as an indicator of the CMC phenotype as recently demonstrated by us and others (He et al., 2003; Jonsson et al., 2010) .
Results

Comparison of CMCs and human heart tissue
The beat frequency of individual CMCs harvested for quantitative gene expression analysis was monitored and beat frequencies spanning from 8 to 148 BPM were noted, mirroring the heterogeneity of the CMC population. In order to group the CMCs based on a functional parameter, the CMCs were divided into two groups, below and above 50 BPM (Figure 1) . The average beat frequency of the slow-beating group was 26 + 2 (SEM) and the corresponding value for the faster-beating group was 89 + 5 (SEM). Previous studies have shown that a slower beating frequency (,50 BPM) is indicative of a ventricular-like phenotype (Jonsson et al., 2010) , and slower spontaneous rate of activity in the ventricularlike cells was also observed the longer the cells were maintained in culture (He et al., 2003) .
Next, the expression levels of the genes NKX2.5, ACTC1, TNNT2, MYH6, MYH7 and PLN coding for the homeobox transcription factor NKX2.5, cardiac muscle actin, cardiac troponin T2, a-myosin heavy chain, b-myosin heavy chain and phospholamban were compared with the corresponding gene expression levels measured in fetal, neonatal and adult human heart tissue. Although no specification of location was available from the purchased fetal heart samples, the neonatal samples were of atrial origin, and the adult samples were from both atrial and ventricular tissue (Figure 2) . The expression of NKX2.5 was several folds higher in the hESC-derived CMCs compared with the human tissue samples, but no difference was observed between the slow and faster beating CMCs. Similarly, the mRNA levels of ACTC1 were higher in the CMCs than in the human heart tissue, and notably, ACTC1 was significantly higher expressed in the faster-beating CMCs compared with the slowerbeating CMC group. The expression of MHY6 was also higher in the faster beating CMCs, and a comparable pattern was observed in the atrial vs. ventricular human tissue samples. On the other hand, the mRNA level of MYH7 was substantially higher in the ventricular tissue than in any other samples analyzed here, including the CMCs. The expression patterns of TNNT2 and PLN also indicated a higher expression level in the ventricular samples compared with the atrial ones (adult and neonatal). No differences in the expression level of any of these genes were observed between the slow and faster beating CMCs. The expression levels of PLN in CMCs were in the range of the ventricular samples whereas the expression of TNNT2 in CMCs rather approached those of the atrial samples.
In a similar way as for the cardiac markers, the expression of genes encoding important ion channels was also investigated. The mRNA levels of KCNH2 (the hERG potassium channel), HCN2 (the channel hyperpolarization-activated cyclic nucleotidemodulated channel subunit 2), HCN4 (the channel hyperpolarization-activated cyclic nucleotide-modulated channel subunit 4), RYR2 (the cardiac ryanodine receptor 2), CACNA1C (the L-type calcium channel) and SCN5A (the sodium channel Nav1.5) were analyzed in CMCs and human heart tissue ( Figure 3 ). The mRNAs of RYR2, CACNA1C and SCN5A were expressed at comparable levels in the CMCs and across the different heart tissue samples. Interestingly, the KCNH2 gene expression levels in the CMCs were most similar to the atrial samples from adult and neonatal sources. On the other hand, HCN2 expression in the CMCs mirrored the expression levels in the ventricular samples. The only gene that was significantly differentially expressed between the two CMC groups was HCN4, and the slower beating CMCs displayed lower HCN4 expression. Notably, the relative difference between the CMC groups paralleled the difference observed between the adult ventricular and atrial samples.
The hERG channel and the L-type calcium channel were studied further at the protein level, together with the HCN4 channel which contributes to the depolarizing 'pacemaker' current in cardiomyocytes. The distribution of these ion channels in CMCs was similar when compared with cardiac adult atrial and ventricular tissue ( Figure 4) .
As an alternative to grouping the CMCs based on beating frequency as shown above, we also analyzed the gene expression data after dividing the individual CMCs into three different groups based on the number of days that had passed from Figure 1 Beat frequency of individual CMCs. The beat frequency of hESC-derived CMCs was registered by visual observations using light microscopy. The graph illustrates the distribution of the beat frequency within the two groups of CMCs (BPM , 50, n ¼ 34 and BPM . 50, n ¼ 32) analyzed and the horizontal lines within each group represent the mean values.
hESC-derived CMCs similar to human heart
Figure 2 mRNA expression of cardiac markers in individual CMCs. Individual CMCs derived from hESC and samples from human heart tissue were analyzed in parallel using real-time qPCR. Two groups of CMCs (BPM , 50, n ¼ 34 and BPM . 50, n ¼ 32) were compared with pools of fetal heart (n ¼ 2), neonatal atrial heart (n ¼ 5), adult ventricular normal heart (n ¼ 2) and adult atrial heart (n ¼ 2). The data were normalized against a common reference sample and are presented as mean + SEM. Statistical significance between the two groups of CMCs was determined using Student's t-test, and all significant differences are indicated. **P , 0.01. hES-CMC, human embryonic stem cell-derived cardiomyocyte cluster.
Figure 3 mRNA expression of ion channels in individual CMCs. Individual CMCs derived from hESC and samples from human heart tissue were analyzed in parallel using real-time qPCR. Two groups of CMC (BPM , 50, n ¼ 34 and BPM . 50, n ¼ 32) were compared with pools of fetal heart (n ¼ 2), neonatal atrial heart (n ¼ 5), adult ventricular normal heart (n ¼ 2) and adult atrial heart (n ¼ 2). The data were normalized against a common reference sample and are presented as mean + SEM. Statistical significance between the two groups of CMCs was determined using Student's t-test, and all significant differences are indicated. ***P , 0.001. hES-CMC, human embryonic stem cell-derived cardiomyocyte cluster.
plating of the three-dimensional-aggregates to the harvest of the CMCs. Thus, the CMCs were classified as: early (1-24 days), intermediate (25 -55 days) and late (60-76 days). As expected, the transcription factor NKX2.5 was significantly downregulated with the age of the CMCs, approaching the levels detected in the human tissue samples. Similarly, ACTC1 displayed a significantly higher expression in early CMCs, although the expression of MHY6 increased with time in culture. For the genes TNNT2, PLN and MYH7 on the other hand, no significant difference in gene expression was observed over time among the CMCs. With regard to the ion-channels investigated, the expression of KCNH2 and HCN4 decreased over time, although the expression of HCN2 and SCN5A was significantly lower in early CMCs. RYR2 and CACNA1C expression did not change significantly over time.
Gene-to-gene correlation
The overall results suggested that CMCs had a gene expression profile similar to human cardiac tissue. To analyze this further and to rule out arbitrary expression of cardiac markers in CMCs, we investigated if there was a correlation between the expression levels of these genes in CMCs similar to what is known about gene expression in cardiac tissue. Therefore, a gene-to-gene correlation at an individual level across all CMCs was performed. Interestingly, the expression of several important genes such as NKX2.5 and KCNH2 were highly correlated with each other, whereas the expression of HCN2 only correlated with MYH6 ( Table 1) . Taken together, most of the genes correlated well with each other (with the exception of HCN2, MYH6 and MYH7). Several cardiac genes have been activated rather than just one and adult atrium (AA) using indirect immunofluorescence with antibodies directed against HCN4, hERG and L-type calcium channels. Nuclei stained with DAPI appear as blue in the online version of this article. Bar ¼ 100 mm.
hESC-derived CMCs similar to human heart or two, indicating that a general cardiac transcriptional program has been activated in the cells. This further underscores the cardiac phenotype of the CMCs.
Functional analysis of CMCs
From the gene expression analysis of ion channels in CMCs (Figure 3) , it was observed that HCN4 was significantly up-regulated in CMC with higher beat frequency. This gene is one of the genes coding for the I f channel, which activity is also involved in the spontaneous contractile activity of CMCs. Therefore, the functional effect of this channel on beat frequency was studied by adding the I f blocker Zatebradine to CMCs. After addition of the compound to CMCs, the beat frequency decreased in a dose-dependent manner ( Figure 5A) . The experiments were repeated in a larger group of CMCs representing the two groups with BPM above and below 50. The beat frequency of 32 individual CMCs was monitored before and after incubation with 5 mM Zatebradine and a significant decrease in BPM was noted after addition of Zatebradine in both groups ( Figure 5B ). This supported the conclusion that functional I f is important for the regulation of spontaneous beat frequency in hESC-derived CMCs in both slow (,50 BPM) and faster (.50 BPM)-beating clusters.
Discussion
In differentiating hESC cultures, CMCs become visible as spontaneously contracting clusters of cells among other non-cardiac cell types. The spontaneous contraction of the CMCs together with their expression of cardiac markers is highly indicative of a cardiac phenotype. However, existing data illustrate that CMCs are heterogeneous. For example, we and others (He et al., 2003; Cui et al., 2007) have observed that beat frequency varies among CMCs (Figure 1 ), and CMCs with diverse cardiomyocyte phenotypes have been noted (He et al., 2003) . Thus, analysis of CMCs as individual samples, as undertaken in the present study, allows a greater insight into the nature of CMCs and it will also allow for specific adjustment of culture protocols to enrich the population towards a desired phenotype. In addition, in order to take advantage of the full potential of CMCs derived from hESCs in various areas such as drug discovery and development, a thorough comparison of CMCs in relation to human heart tissue is needed. Here, we compared individual CMCs to fetal, neonatal and adult heart, the latter of both atrial and ventricular origin, in order to evaluate the potential use of the CMCs for in vitro models representing human heart tissue. Although this study compared the complex in vivo situation with the more defined cell population of a CMC, expression data for cardiac markers and ion channels showed similarities to the human heart (Figures 2 and 3) . Interestingly, ACTC1 and MYH6 were up-regulated in CMCs with BPM above 50, which could reflect CMCs with a more atrial-like phenotype. The gene expression of NKX2.5 was substantially higher in the CMCs compared with any of the human heart tissues analyzed, although no difference was observed between the two CMC groups. This is, however, not surprising since NKX2.5 is known to be highly expressed in hESC-derived cardiomyocytes. This transcription factor plays a critical role in cardiomyocyte commitment and differentiation and its relatively high expression level may reflect the early maturation stage of the hESC-derived cardiomyocytes , as also evidenced by their spontaneous contraction. The abundant expression of MHY7 observed in the ventricular human heart tissues is also in line with previous results (Sharma et al., 2003) .
Overall, the expression of ion-channels was remarkably similar between the different samples analyzed here. It is not obvious that an in vitro derived cell population (i.e. the CMCs) would recapitulate the gene expression levels observed in human biopsies of the corresponding tissue type. Basically, it was only HCN4 that was notably differentially expressed between the CMCs and heart tissue samples. Interestingly, HCN4 was also observed to be significantly up-regulated in the group of CMCs displaying higher Figure 5 The effect of the I f channel blocker Zatebradine on CMC beat frequency. (A) CMCs were generated from hESCs and Zatebradine was administered to the cells in a cumulative dose escalating manner. The beat frequency was monitored visually using light microscopy and the data are presented as mean + SEM (n ¼ 11). Statistical significance was determined using repeated measures ANOVA for multiple groups with Dunnett's post test and **P , 0.01 vs. control (0 mM). (B) CMCs were generated from hESCs and their beat frequency was monitored visually using light microscopy before (2) and after (+) administration of 5 mM Zatebradine. The data are presented as mean + SEM (BPM , 50, n ¼ 8 and BPM . 50, n ¼ 24), and statistical significance between untreated (2) and treated (+) CMCs was determined using the paired Student's t-test. ***P , 0.001, **P , 0.01 vs. respective control (hES-CMC, human embryonic stem cell-derived cardiomyocyte cluster).
beat frequency compared with the slower beating group. This profile was also noted for the comparison of the ventricular vs. atrial human heart tissue samples included here, which is further supported by other studies demonstrating a higher expression in atria vs. ventricles (Gaborit et al., 2007) . HCN4 is one of several isoforms of the HCN family that are present in the heart. The relative expression level of the different forms varies with region and age and the expression pattern of the isoforms HCN2 and HCN4 in CMC versus human heart tissues recorded in this study are in concurrence with mammalian heart development. Moreover, the ratio of HCN2 to HCN4 was found to increase with age in rat (Shi et al., 1999) , also in line with our results. The HCN family of genes is responsible for the expression of I f , which has traditionally been associated with pacemaker cells in the heart, but it has also been located in atrial and ventricular myocytes from both animal models and humans (Robinson and Siegelbaum 2003) . Immunohistochemistry confirmed that the I f channel, in addition to the key ion channels hERG potassium channel and the L-type calcium channel, was present at the protein level as well in CMCs (Figure 4) . The results were directly comparable with sections of adult atrial and ventricular tissue. Functional analysis of I f with the inhibitor Zatebradine illustrates that this current is active in each of the CMC groups studied ( Figure 5) . One interesting future study will be to chart, in detail, the functionality of other key ion channels between faster and slow-beating CMCs.
To explore the inter-relationship between the genes expressed and analyzed in the CMCs in this study, the gene expression data were further processed to investigate any correlations among pairs of genes. A significant correlation was found between the early cardiac transcription factor NKX2.5 and all the other genes studied here, except for MYH6 and HCN2. In mouse perinatal Nkx2.5 knockout hearts, a reduction in the mRNA levels of Ryr2 and Nav1.5a has previously been described (Briggs et al., 2008) . On the other hand, NKX2.5 failed to significantly activate expression of the MYH6 gene in human cells (van Tuyn et al., 2007) , an observation supported by the results presented here.
In conclusion, this study expands the evidence for the suitability of hESC-derived CMCs as surrogates for human cardiac tissue. We provide a direct comparison between CMCs and fetal, atrial neonatal and atrial and ventricular adult human heart tissue, and the results demonstrate a clear similarity of the in vitro and in vivo sourced material. Thus, it appears reasonable to suggest that CMCs can be applied as an in vitro model of human cardiogenesis for cell and developmental biology, and in studies of the regulation of cardiac gene expression levels during heart formation. In addition, the development and validation of new and improved in vitro applications for drug development based on the CMCs, as recently suggested (Braam et al., 2010; Liang et al., 2010) seem justified. Taking advantage of the functional properties of these cells, of human origin, may help to address critical issues for the pharmaceutical industry by providing new models and tools for several areas in drug development, including drug safety assessment. Improved predictability in pre-clinical investigations is expected to contribute to a decreased rate of costly late stage attrition.
Materials and methods
Human cardiac tissue samples
All biopsies were obtained after written, informed consent from patients undergoing heart surgery and after ethical approval by the Research Ethics Board at University of Gothenburg and the Sahlgrenska Academy, Gothenburg, Sweden. Human biopsies from auricle of right atrium were obtained from five neonatal subjects (mean age 12 days old, range 6 -17 days) and four adult subjects (mean age 65 years old, range 58-74 years). For immunofluorescence, a human left ventricle was also obtained from an explanted heart from an adult transplant recipient with ischemic heart failure. Total RNA from fetal heart, ages 18-21 weeks old from a pool of hearts from two fetuses and 12 -31 weeks old from a pool of 34 normal hearts from spontaneously aborted fetuses, were purchased from Stratagene (La Jolla, CA, USA) and Clontech (Mountain View, CA, USA), respectively. Normal ventricular total RNA from two individual adult subjects were purchased from Ambion (Austin, TX, USA) for gene expression analysis.
Human ESC culture and differentiation to CMCs
The hESC line SA002 (Cellartis AB, Gothenburg, Sweden) was propagated as previously described (Heins et al., 2004 (Heins et al., , 2006 on mitomycin-C (Sigma-Aldrich, St. Louis, MO, USA) inactivated mouse embryonic fibroblast feeder layers using VitroHES medium (Vitrolife AB, Kungsbacka, Sweden) supplemented with 4 ng/ml basic fibroblast growth factor. Human ESCs were differentiated to obtain spontaneously beating CMCs, essentially as described previously (Synnergren et al., 2008) . Briefly, hESC colonies were released from the feeder layers using collagenase and subjected to forced aggregation in 96-well plates (Burridge et al., 2007) . After 3-7 days, the formed three-dimensional-aggregates were plated onto gelatine-coated culture dishes and incubated in Dulbecco's modified Eagle's medium (DMEM) supplemented with 20% fetal bovine serum (FBS), 1 mM GlutaMAX, 0.1 mM b-mercaptoethanol, 1% MEM nonessential amino acids and 1% penicillin-streptomycin solution (all from Invitrogen, Carlsbad, CA, USA). The medium was changed every 2-3 days. Spontaneously contracting CMCs were identified by visual inspection using light microscopy and harvested by mechanical dissection. Specific care was taken only to harvest the beating areas with a minimum of surrounding non-contracting cells. For RNA extractions, harvested CMCs were rapidly frozen at 2808C. Individual CMCs were divided into two different groups based on their beat frequency (,50 and .50 BPM, respectively).
protocol. The instrument 7900HT, software and reagents for the real-time qPCR analysis were purchased from Applied Biosystems (Applied Biosystems, Foster City, CA, USA). Briefly, cDNA was prepared from total RNA using HighCapacity cDNA Reverse Transcription Kit. The following human TaqMan Gene Expression Assays were used: NKX2.5 Hs00231763_m1, ACTC1 Hs0060 6316_m1, TNNT2 Hs00165960_m1, MYH6 Hs01101425_m1, MYH7 Hs00165276_m1, PLN Hs00160179_m1, KCNH2 Hs00165 120_m1, HCN2 Hs00606903_m1, HCN4 Hs00175760_m1, RYR2 Hs00181461_m1, CACNA1C Hs00167681_m1 and SCN5A Hs00165693_m1. CREBBP Hs00231733_m1 was used as an endogenous reference gene, since this gene has previously been reported as suitable in stem cell studies (Synnergren et al., 2007) . All samples were analyzed in duplicates. The relative comparative C T method was used to analyze the real-time qPCR data (User Bulletin #2, Applied Biosystems).
Immunofluorescence CMC sections were fixed in 4% paraformaldehyde for 10 min, permeabilized for 5 min in 0.5% saponin solution (Sigma-Aldrich) in Dulbecco's phosphate buffered saline and subsequently blocked with 5% FBS in phosphate buffered saline (PBS) (Invitrogen) for 30 min. The cells were incubated with primary antibody solution overnight at 48C. The primary antibodies used were specific for I f (Ab39992), hERG (Ab32585) and the L-type calcium channel (Ab2862), all purchased from Abcam (Cambridge, UK). Incubation with Alexa 488 or Cy3-conjugated secondary antibodies (Jackson Immunoresearch Laboratories, West Grove, PA, USA) was performed for 60 min at room temperature. Nuclei were stained with DAPI (4 ′ ,6-Diamidino-2-phenylindole, Sigma-Aldrich). The stained sections were evaluated and documented using a Nikon Eclipse TE-2000 U fluorescence microscope (Nikon, Tokyo, Japan) and compared with the respective isotype control. Human heart sections were heated for 120 min at 568C, and washed in Xylene and ethanol (99, 95 and 70%) and PBS. To retrieve antigens, the sections were heated for 3 min in 10 mM Tris-EDTA, pH 9 and subsequently stained as described above.
Functional assessment of I f in CMCs
The I f blocker Zatebradine (Z0127, Sigma-Aldrich) was administered to isolated, individual, spontaneously beating CMCs. The beat frequency was registered visually every other minute until the effect of the substance had declined, and the minimal beats-per-minute value obtained was considered the maximal effect at each concentration tested.
Statistical analysis
Statistical significance was determined using Student's t-test for two groups or ANOVA for multiple groups with Dunnett's post test as indicated. Logarithmic values of the gene expression data were used for the statistical calculations. A value of P , 0.05 was considered statistically significant.
